These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 9251874)

  • 1. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
    Cady RK; Gutterman D; Saiers JA; Beach ME
    Cephalalgia; 1997 Aug; 17(5):588-90. PubMed ID: 9251874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
    Olesen J
    Cephalalgia; 1997 Aug; 17(5):559. PubMed ID: 9251869
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.
    Lipton RB; Stewart WF; Cady R; Hall C; O'Quinn S; Kuhn T; Gutterman D
    Headache; 2000; 40(10):783-91. PubMed ID: 11135021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study.
    Carpay JA; Linssen WH; Koehler PJ; Arends LR; Tiedink HG
    Headache; 2003 Apr; 43(4):395-9. PubMed ID: 12656711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs.
    Schulman EA; Dermott KF
    Headache; 2003; 43(7):729-33. PubMed ID: 12890127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of autogenic training on drug consumption in patients with primary headache: an 8-month follow-up study.
    Zsombok T; Juhasz G; Budavari A; Vitrai J; Bagdy G
    Headache; 2003 Mar; 43(3):251-7. PubMed ID: 12603644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rizatriptan in the spectrum of headache.
    Allen C; Cady R; Lines C; McCarroll K
    Headache; 2001 Jun; 41(6):607-8. PubMed ID: 11437904
    [No Abstract]   [Full Text] [Related]  

  • 13. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medication-overuse headache].
    Rabe K; Katsarava Z
    MMW Fortschr Med; 2006 Aug; 148(35-36):37-8. PubMed ID: 16995362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of nasal sumatriptan in 5- to 12-year-old children.
    Hershey AD; Powers SW; LeCates S; Bentti AL
    Headache; 2001; 41(7):693-7. PubMed ID: 11554957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication patterns of recurrent headache sufferers: a community study.
    Forward SP; McGrath PJ; MacKinnon D; Brown TL; Swann J; Currie EL
    Cephalalgia; 1998 Apr; 18(3):146-51. PubMed ID: 9595208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses.
    Salonen R; Saiers J
    Cephalalgia; 1999 Jan; 19(1):16-9. PubMed ID: 10099854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.
    Freitag FG; Cady R; DiSerio F; Elkind A; Gallagher RM; Goldstein J; Klapper JA; Rapoport AM; Sadowsky C; Saper JR; Smith TR
    Headache; 2001 Apr; 41(4):391-8. PubMed ID: 11318886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.